The complex structure of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Expanding the Genetic Landscape ofNeurology. Genetics · 2026
   Article
2. Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis.Acta neuropathologica communications · 2025
   Article
3. Spinocerebellar Ataxia Type 2: A Review and Personal Perspective.Neurology. Genetics · 2025
   Review
4. ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS).Neurogenetics · 2025
   Article
5. Ataxia and Parkinsonism in a Woman With a VCP Variant and Long-Normal Repeats in the SCA2 Allele.Neurology. Genetics · 2021
   Article
6. Erratum: The complex structure of ATXN2 genetic variation.Neurology. Genetics · 2019
   Article

Corrections and comments

• Comment on
  Homozygous 31 trinucleotide repeats in the SCA2 allele are pathogenic for cerebellar ataxia.2018
• Erratum issued
  Erratum: The complex structure of ATXN2 genetic variation.2019

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.